Aspirin anti-inflammatory action linked to cardiovascular disease prevention -- NEJM.
This article was originally published in The Tan Sheet
Executive Summary
ASPIRIN ANTI-INFLAMMATORY ACTION LINKED TO CARDIOVASCULAR DISEASE PREVENTION in a study by Paul Ridker, MD, Brigham & Women's Hospital, et al., published in the April 3 New England Journal of Medicine. The analysis involved 1,086 men who participated in the Physicians' Health Study and were randomly assigned regular doses of either 325 mg of aspirin or placebo. The study found that blood levels of C-reactive protein, a marker for systemic inflammation, could predict risk of first myocardial infarction and stroke.